GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5682 CYM 50358 hydrochlorideSummary: S1P4 antagonist
- B5687 PU 02Summary: negative allosteric modulator of 5-HT3 receptors
- B5688 LP 20 hydrochlorideSummary: ligand of the 5-HT7 receptor
- B5689 TC LPA5 4Summary: LPA5 receptor antagonist
- B5701 TC-G 1006Summary: sphingosine-1-phosphate receptor 1 (S1P1) agonist
- B5702 ML 221Summary: Apelin receptor (APJ) antagonist
- B5705 Q94 hydrochlorideTarget: PAR receptorSummary: PAR1 negative allosteric modulator
- B5706 COR 170Summary: inverse agonist of CB2 receptors
- B5710 BETPSummary: glucagon-like peptide 1 (GLP-1) receptor modulator
- B5711 VUF 11207 fumarateSummary: ACKR3 (CXCR7) chemokine receptor agonist